| # | Title | Journal | Year | Citations |
|---|
| 1 | The genomic landscape of hypodiploid acute lymphoblastic leukemia | Nature Genetics | 2013 | 588 |
| 2 | Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia | Nature Communications | 2015 | 281 |
| 3 | Coronavirus disease 2019 in patients with inborn errors of immunity: An international study | Journal of Allergy and Clinical Immunology | 2021 | 278 |
| 4 | Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse | Nature Genetics | 2013 | 264 |
| 5 | A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor | Nature Genetics | 2017 | 255 |
| 6 | Recurrent DGCR8, DROSHA, and SIX Homeodomain Mutations in Favorable Histology Wilms Tumors | Cancer Cell | 2015 | 244 |
| 7 | Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia | Nature Communications | 2016 | 218 |
| 8 | Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group Study | Blood | 2012 | 210 |
| 9 | Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas | Nature Communications | 2019 | 200 |
| 10 | Assessment of 2q23.1 Microdeletion Syndrome Implicates MBD5 as a Single Causal Locus of Intellectual Disability, Epilepsy, and Autism Spectrum Disorder | American Journal of Human Genetics | 2011 | 195 |
| 11 | Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study | Lancet Oncology, The | 2015 | 161 |
| 12 | SPEG Interacts with Myotubularin, and Its Deficiency Causes Centronuclear Myopathy with Dilated Cardiomyopathy | American Journal of Human Genetics | 2014 | 143 |
| 13 | Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children’s Oncology Group study | British Journal of Cancer | 2015 | 114 |
| 14 | The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children’s Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial | Blood | 2014 | 109 |
| 15 | Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children’s Oncology Group Trial AALL0331 | Journal of Clinical Oncology | 2020 | 107 |
| 16 | Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia | Nature | 2018 | 90 |
| 17 | Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group | Clinical Cancer Research | 2016 | 82 |
| 18 | Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group | Pediatric Blood and Cancer | 2017 | 82 |
| 19 | Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children | Nature Communications | 2015 | 72 |
| 20 | Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology Group | Cancer | 2013 | 67 |
| 21 | Phf6 Loss Enhances HSC Self-Renewal Driving Tumor Initiation and Leukemia Stem Cell Activity in T-ALL | Cancer Discovery | 2019 | 67 |
| 22 | MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours | Nature Communications | 2015 | 64 |
| 23 | Mutation-Specific SARS-CoV-2 PCR Screen: Rapid and Accurate Detection of Variants of Concern and the Identification of a Newly Emerging Variant with Spike L452R Mutation | Journal of Clinical Microbiology | 2021 | 60 |
| 24 | Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested? | Bone Marrow Transplantation | 2015 | 59 |
| 25 | IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis | JCI Insight | 2018 | 59 |
| 26 | A Systematic Review on Predisposition to Lymphoid (B and T cell) Neoplasias in Patients With Primary Immunodeficiencies and Immune Dysregulatory Disorders (Inborn Errors of Immunity) | Frontiers in Immunology | 2019 | 59 |
| 27 | Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1‐deficient non‐rhabdoid tumor with favorable long‐term outcome | Brain Pathology | 2017 | 58 |
| 28 | Contactin 4 as an autism susceptibility locus | Autism Research | 2011 | 57 |
| 29 | Variability in interpreting and reporting copy number changes detected by array-based technology in clinical laboratories | Genetics in Medicine | 2009 | 53 |
| 30 | Genomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: A report from the Children's Oncology Group | Genes Chromosomes and Cancer | 2012 | 53 |
| 31 | Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low‐Risk Clinical Features: A Report From the Children's Oncology Group | Pediatric Blood and Cancer | 2016 | 53 |
| 32 | Biodistribution of onasemnogene abeparvovec DNA, mRNA and SMN protein in human tissue | Nature Medicine | 2021 | 49 |
| 33 | Molecular diagnostics in the management of rhabdomyosarcoma | Expert Review of Molecular Diagnostics | 2017 | 48 |
| 34 | TCF21 hypermethylation in genetically quiescent clear cell sarcoma of the kidney | Oncotarget | 2015 | 46 |
| 35 | Variability in pathogenicity prediction programs: impact on clinical diagnostics | Molecular Genetics & Genomic Medicine | 2015 | 44 |
| 36 | Reciprocal deletion and duplication at 2q23.1 indicates a role for MBD5 in autism spectrum disorder | European Journal of Human Genetics | 2014 | 42 |
| 37 | Impact of the Updated Guidance for Palivizumab Prophylaxis against Respiratory Syncytial Virus Infection: A Single Center Experience | Journal of Pediatrics | 2017 | 41 |
| 38 | Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy | Oncotarget | 2017 | 41 |
| 39 | Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy | Genetics in Medicine | 2012 | 39 |
| 40 | RINT1 Bi-allelic Variations Cause Infantile-Onset Recurrent Acute Liver Failure and Skeletal Abnormalities | American Journal of Human Genetics | 2019 | 39 |
| 41 | Septal dysembryoplastic neuroepithelial tumor: a comprehensive clinical, imaging, histopathologic, and molecular analysis | Neuro-Oncology | 2019 | 38 |
| 42 | Clinical and Virologic Characteristics May Aid Distinction of Acute Adenovirus Disease from Kawasaki Disease with Incidental Adenovirus Detection | Journal of Pediatrics | 2016 | 37 |
| 43 | Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia | JAMA Oncology | 2022 | 36 |
| 44 | Oncolytic Herpes Virus rRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors | Molecular Therapy - Oncolytics | 2017 | 35 |
| 45 | MiR‐1253 exerts tumor‐suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7‐H3) | Brain Pathology | 2020 | 35 |
| 46 | Urine Culture Follow-up and Antimicrobial Stewardship in a Pediatric Urgent Care Network | Pediatrics | 2017 | 34 |
| 47 | Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia | Blood Advances | 2018 | 34 |
| 48 | The effects of frozen tissue storage conditions on the integrity of RNA and protein | Biotechnic and Histochemistry | 2014 | 33 |
| 49 | Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity | Molecular Therapy - Oncolytics | 2014 | 33 |
| 50 | Mixed‐phenotype acute leukemia: A cohort and consensus research strategy from the Children’s Oncology Group Acute Leukemia of Ambiguous Lineage Task Force | Cancer | 2020 | 32 |
